NHS talking therapies help people with dementia

Talking therapies available on the NHS could improve the mental health of people with dementia if they suffer from anxiety or depression, researchers at UCL have found.

Studies suggest that 38% of people with dementia are affected by anxiety or depression, but the new research found that completing a course of IAPT treatment – the “Improving Access to Psychological Therapies programme available nationally on the NHS – could be beneficial for this group.

Researchers examined data from more than 2.5 million people who had had clinically significant anxiety or depression and undertaken a course of IAPT treatment.  These included 1,549 people with a dementia diagnosis.

It was discovered that the treatment reduced mental health symptoms in 63% of those with dementia and approximately 40% recovered entirely.

“This is the largest ever study to investigate outcomes of psychological therapies in people living with dementia,” said lead author Georgia Bell. “Our findings suggest that while people with dementia are less likely to improve or recover than those without dementia, psychological therapies offered in primary

Similar Posts

  • Care worker vacancies

    Figures from Skills for Care reveal that care worker vacancies have fallen from a historic high of 165,000 last year to just over 150,000. While the vacancy rate remains above pre-pandemic levels, it will provide some reassurance in a sector that has been struggling with skills shortages. Responding to the report, Nuffield Trust deputy policy…

  • Diagnosis benefits

    Nine in every 10 people affected by dementia believe that there are benefits from getting a diagnosis, according to survey results published by Alzheimer’s Society to mark Dementia Action Week (16-22 May). A survey of just over 1,000 people found that 91% saw at least one benefit and on average respondents mentioned 2.5 benefits, including…

  • New transdermal patch

    An easier way to administer an established treatment for Alzheimer’s disease has been developed by Luye Pharma.  The twice weekly Zeyzelf rivastigmine transdermal patch is said by the company to be simpler than the daily rivastigmine patches already in circulation.  It is also 52% less expensive than some other patches, the company says. Rivastigmine reduce…

  • More News from UKDC

    Research priorities Research programmes have tended to focus on finding a disease-modifying treatment for Alzheimer’s, but how can we channel more funding into research to improve care and quality of life? Read More Work with local communities Former Department of Health (DH) civil servant Ruth Eley – now chair of the carer involvement group tide…

  • Reports from UKDC 2023

    Aston University in Birmingham played host to the 17th UK Dementia Congress (UKDC) last week (November 7 & 8) when delegates from every corner of the sector came together for a lively and thought-provoking conference and exhibition. Celebration and concern Graham Stokes, from UKDC’s main sponsor HC-One, kicked off the proceedings by reminding the audience…

  • Christmas playlist

    The charity Music for my Mind promises the “ultimate Christmas playlist” if people respond to its appeal for their favourite festive tunes.  Music for my Mind says it will share the resulting playlist on its social media channels.  Just send your favourites, including those of people living with dementia or memory loss, to this email…